Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa.
作者信息
Besselaar Terry G, Naidoo Dhamari, Buys Amelia, Gregory Vicky, McAnerney Jo, Manamela Jack M, Blumberg Lucille, Schoub Barry D
出版信息
Emerg Infect Dis. 2008 Nov;14(11):1809-10. doi: 10.3201/eid1411.080958.
Abstract
摘要
相似文献
1
Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa.南非甲型流感病毒（H1N1）中广泛存在的奥司他韦耐药性
Emerg Infect Dis. 2008 Nov;14(11):1809-10. doi: 10.3201/eid1411.080958.
2
Global transmission of oseltamivir-resistant influenza.耐奥司他韦流感病毒的全球传播。
N Engl J Med. 2009 Mar 5;360(10):953-6. doi: 10.1056/NEJMp0900648. Epub 2009 Mar 2.
3
Global emergence of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses with I223V and S247N mutations: implications for antiviral resistance monitoring.具有I223V和S247N突变的对神经氨酸酶抑制剂耐药的甲型H1N1pdm09流感病毒在全球出现：对抗病毒耐药性监测的影响
Lancet Microbe. 2024 Jul;5(7):627-628. doi: 10.1016/S2666-5247(24)00037-5. Epub 2024 Mar 14.
4
Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.预防期间出现对奥司他韦耐药的大流行性H1N1病毒。
N Engl J Med. 2009 Dec 3;361(23):2296-7. doi: 10.1056/NEJMc0910060. Epub 2009 Nov 11.
5
Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023-February 2024.多国出现对奥司他韦抑制作用减弱的甲型 H1N1pdm09 流感病毒，2023 年 5 月-2024 年 2 月。
Emerg Infect Dis. 2024 Jul;30(7):1410-1415. doi: 10.3201/eid3007.240480.
6
Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir.在一名接受奥司他韦和扎那米韦治疗的免疫功能低下儿童中出现耐多药甲型H1N1pdm09流感病毒变异株
J Infect Dis. 2015 Oct 15;212(8):1209-13. doi: 10.1093/infdis/jiv245. Epub 2015 May 5.
7
Drug resistance. A 'wimpy' flu strain mysteriously turns scary.耐药性。一种“软弱”的流感毒株神秘地变得可怕起来。
Science. 2009 Feb 27;323(5918):1162-3. doi: 10.1126/science.323.5918.1162.
8
Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.2004年至2008年全球流行的甲型和乙型人流感病毒中神经氨酸酶抑制剂耐药性监测
Antimicrob Agents Chemother. 2008 Sep;52(9):3284-92. doi: 10.1128/AAC.00555-08. Epub 2008 Jul 14.
9
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.2007 - 2008年流感季节，欧洲出现对奥司他韦耐药的甲型流感病毒（H1N1）
Emerg Infect Dis. 2009 Apr;15(4):552-60. doi: 10.3201/eid1504.181280.
10
Oseltamivir resistance: what does it mean clinically?奥司他韦耐药性：临床意义何在？
Clin Infect Dis. 2009 Dec 15;49(12):1836-7. doi: 10.1086/648425.
引用本文的文献
1
Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.预测能够改善携带 H275Y 神经氨酸酶取代的 A(H1N1)pdm09 病毒适应性的许可性突变。
J Virol. 2022 Aug 10;96(15):e0091822. doi: 10.1128/jvi.00918-22. Epub 2022 Jul 14.
2
Molecular Epidemiology and Evolutionary Dynamics of Human Influenza Type-A Viruses in Africa: A Systematic Review.非洲甲型流感病毒的分子流行病学与进化动力学：一项系统综述
Microorganisms. 2022 Apr 25;10(5):900. doi: 10.3390/microorganisms10050900.
3
Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine.流感 A 病毒核糖核蛋白复合物温度敏感突变导致活减毒流感疫苗减毒。
Viruses. 2018 Oct 15;10(10):560. doi: 10.3390/v10100560.
4
Epidemiology of circulating human influenza viruses from the Democratic Republic of Congo, 2015.2015 年刚果民主共和国循环人流感病毒的流行病学。
PLoS One. 2018 Sep 28;13(9):e0203995. doi: 10.1371/journal.pone.0203995. eCollection 2018.
5
Replacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South Africa.2008 年南非出现对神经氨酸酶抑制剂敏感的甲型 H1N1 流感病毒耐药表型的取代，以及 2009-2013 年期间对神经氨酸酶抑制剂敏感的甲型和乙型流感病毒的流行。
Influenza Other Respir Viruses. 2019 Jan;13(1):54-63. doi: 10.1111/irv.12611. Epub 2018 Oct 31.
6
In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1.甲型H1N1流感病毒神经氨酸酶抑制剂奥司他韦的计算机模拟修饰
J Biomed Res. 2015 Apr;29(2):150-9. doi: 10.7555/JBR.29.20130024. Epub 2014 Dec 12.
7
A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade.过去十年人类和禽流感病毒的抗病毒易感性综述
Scientifica (Cairo). 2014;2014:430629. doi: 10.1155/2014/430629. Epub 2014 Apr 2.
8
Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice.法匹拉韦与奥司他韦联合用药对小鼠体内野生型大流行甲型流感病毒感染及耐奥司他韦甲型流感病毒感染的协同作用
Future Virol. 2013 Nov;8(11):1085-1094. doi: 10.2217/fvl.13.98.
9
The Emergence of Oseltamivir-Resistant Seasonal Influenza A (H1N1) Virus in Korea During the 2008-2009 Season.2008 - 2009年期间韩国出现对奥司他韦耐药的季节性甲型流感（H1N1）病毒。
Osong Public Health Res Perspect. 2011 Dec;2(3):178-85. doi: 10.1016/j.phrp.2011.11.042.
10
Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.2011 年南半球流感季节期间全球流行的流感病毒神经氨酸酶抑制剂敏感性监测。
Influenza Other Respir Viruses. 2013 Sep;7(5):645-58. doi: 10.1111/irv.12113. Epub 2013 Apr 10.
本文引用的文献
1
Observed oseltamivir resistance in seasonal influenza viruses in Europe interpretation and potential implications.欧洲季节性流感病毒中观察到的奥司他韦耐药性：解读与潜在影响
Euro Surveill. 2008 Jan 31;13(5):8025. doi: 10.2807/ese.13.05.08025-en.
2
Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe.欧洲甲型H1N1流感病毒对奥司他韦耐药性的出现。
Euro Surveill. 2008 Jan 31;13(5):8026. doi: 10.2807/ese.13.05.08026-en.
3
Assay to detect H5N1 oseltamivir resistance.检测H5N1对奥司他韦耐药性的试验。
Emerg Infect Dis. 2006 Dec;12(12):1995-6. doi: 10.3201/eid1212.060673.
4
Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity.在酶活性位点具有新型疏水相互作用的流感神经氨酸酶抑制剂：具有强效抗流感活性的碳环唾液酸类似物的设计、合成及结构分析
J Am Chem Soc. 1997 Jan 29;119(4):681-90. doi: 10.1021/ja963036t.
5
Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.来自澳大拉西亚和东南亚的人类流感病毒对神经氨酸酶抑制剂扎那米韦和奥司他韦的敏感性。
Antiviral Res. 2004 Apr;62(1):37-45. doi: 10.1016/j.antiviral.2003.11.008.
6
Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network.使用不同底物的神经氨酸酶酶法检测评估流感病毒临床分离株对神经氨酸酶抑制剂的敏感性：神经氨酸酶抑制剂敏感性网络报告
J Clin Microbiol. 2003 Feb;41(2):742-50. doi: 10.1128/JCM.41.2.742-750.2003.
7
Impact of the introduction of A/Sydney/5/97 H3N2 influenza virus into South Africa.
J Med Virol. 1999 Dec;59(4):561-8. doi: 10.1002/(sici)1096-9071(199912)59:4<561::aid-jmv22>3.0.co;2-5.
Zotero 插件